|
|
||||||||
From the Department of Neurology (Drs. Huang, Chu, Lu, and Chen), Chang Gung Memorial Hospital and Medical College, Taipei, Taiwan; and the Division of Neurology (Dr. Calne), Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, Canada.
Address correspondence and reprint requests to Dr. C.-C. Huang, Department of Neurology, Chang Gung Memorial Hospital, 199 Tung Hwa North Road, Taipei, Taiwan.
We studied the long-term clinical course of five patients with chronic manganese intoxication. The mean scores of the King's College Hospital Rating Scale for Parkinson's disease increased from 15.0 ± 4.2 in 1987 to 28.3 ± 6.70 in 1991 and then to 38.1 ± 12.9 in 1995. The deterioration was most prominent in gait, rigidity, speed of foot tapping, and writing. Tissue concentrations of manganese in blood, urine, scalp hair, and pubic hair returned to normal. Follow-up MRIs did not show paramagnetic high-signal intensity on T1-weighted images. The data indicate that clinical progression in patients with manganese parkinsonism continues even 10 years after cessation of exposure.
Supported by a grant from the National Science Council(NSC86-2314-B182A-048). PETs were also supported by the National Parkinson Foundation, the Parkinson Foundation of Canada, and The Movement Disorder Institute.
Received April 8, 1997. Accepted in final form September 5, 1997.
This article has been cited by other articles:
![]() |
R. M. A. de Bie, R. M. Gladstone, A. P. Strafella, J.-H. Ko, and A. E. Lang Manganese-Induced Parkinsonism Associated With Methcathinone (Ephedrone) Abuse Arch Neurol, June 1, 2007; 64(6): 886 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kumar, A. A. Cohen-Gadol, R. A. Wright, G. M. Miller, D. G. Piepgras, and J. E. Ahlskog Superficial siderosis Neurology, April 25, 2006; 66(8): 1144 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kumar, E. P. Lindell, J. A. Wilden, and D. H. Davis Role of dynamic CT myelography in identifying the etiology of superficial siderosis Neurology, August 9, 2005; 65(3): 486 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jankovic Searching for a relationship between manganese and welding and Parkinson's disease Neurology, June 28, 2005; 64(12): 2021 - 2028. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Josephs, J. E. Ahlskog, K. J. Klos, N. Kumar, R. D. Fealey, M. R. Trenerry, and C. T. Cowl Neurologic manifestations in welders with pallidal MRI T1 hyperintensity Neurology, June 28, 2005; 64(12): 2033 - 2039. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Filipov, R. F. Seegal, and D. A. Lawrence Manganese Potentiates In Vitro Production of Proinflammatory Cytokines and Nitric Oxide by Microglia Through a Nuclear Factor kappa B-Dependent Mechanism Toxicol. Sci., March 1, 2005; 84(1): 139 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Koller, K. E. Lyons, and W. Truly Effect of levodopa treatment for parkinsonism in welders: A double-blind study Neurology, March 9, 2004; 62(5): 730 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Sadek, R. Rauch, and P. E. Schulz Parkinsonism due to Manganism in a Welder International Journal of Toxicology, September 1, 2003; 22(5): 393 - 401. [Abstract] [PDF] |
||||
![]() |
P. R. Burkhard, J. Delavelle, R. Du Pasquier, and L. Spahr Chronic Parkinsonism Associated With Cirrhosis: A Distinct Subset of Acquired Hepatocerebral Degeneration Arch Neurol, April 1, 2003; 60(4): 521 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Sadak, P. E. Schulz, B. A. Racette, and J. S. Perlmutter Welding-related parkinsonism: Clinical features, treatment, and pathophysiology Neurology, November 13, 2001; 57(9): 1738 - 1739. [Full Text] [PDF] |
||||
![]() |
S. Bleich, D. Degner, R. Sprung, A. Riegel, W. Poser, and E. Rüther Chronic Manganism: Fourteen Years of Follow-up J Neuropsychiatry Clin Neurosci, February 1, 1999; 11(1): 117 - 117. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |